Quick Answer
Tectonic Therapeutic, Inc. reported Cash and Equivalents of $253.80 million for fiscal year 2025.
Tectonic Therapeutic, Inc. Cash and Equivalents — Annual History
| Fiscal Year | Cash and Equivalents | YoY Change |
|---|---|---|
| 2025 | $253.80M | +79.7% |
| 2024 | $141.24M | +390.9% |
| 2023 | $28.77M | -68.9% |
| 2022 | $92.56M | -51.2% |
| 2021 | $189.57M | -27.0% |
| 2020 | $259.68M | +38.8% |
| 2019 | $187.04M | +48.1% |
| 2018 | $126.30M | +2018.1% |
| 2017 | $5.96M | — |
Quarterly Cash and Equivalents
| Quarter Ending | Cash and Equivalents | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $268.44M | +68.7% | -6.6% |
| June 30, 2025 | $287.38M | +55.2% | -6.2% |
| March 31, 2025 | $306.25M | +1533.5% | +116.8% |
| December 31, 2024 | $141.24M | +390.9% | -11.2% |
| September 30, 2024 | $159.09M | +2413.3% | -14.1% |
| June 30, 2024 | $185.12M | +1139.8% | +887.4% |
| March 31, 2024 | $18.75M | -74.1% | -34.8% |
| December 31, 2023 | $28.77M | -68.9% | +354.5% |
- Tectonic Therapeutic, Inc. showed an increase of +79.7% in Cash and Equivalents compared to the prior fiscal year.
- Over the 2017–2025 period, Tectonic Therapeutic, Inc.’s cash and equivalents has grown by 4156.2% (from $5.96 million to $253.80 million).
- The most recent figure is from Tectonic Therapeutic, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: